Release Therapeutics Announces New CEO to Drive Best-in-Class CNS Innovation [Yahoo! Finance]
Zimmer Biomet Holdings, Inc. (ZBH)
Last zimmer biomet holdings, inc. earnings: 2/4 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investor.zimmerbiomet.com
Company Research
Source: Yahoo! Finance
GENEVA, June 27, 2024 (GLOBE NEWSWIRE) -- Release Therapeutics (‘Release Tx' or ‘the Company'), a privately-held, Swiss BioMedTech company, announced today the appointment of Thomas Mehrling, MD, PhD, as CEO. The appointment follows the recent strategic pivot of Release Tx (formerly, ‘MaxiVax') towards treating genetic disorders of the central nervous system (CNS) with a best-in-class cell macroencapsulation technology as an alternative to gene therapy. With over 25 years' experience in multinational pharma companies, including Takeda, Mundipharma International and Hoffmann-La Roche, Dr. Mehrling is an expert in developing novel oncology compounds from bench to bedside. During his tenure at MundiPharma International (2003–2013), he oversaw the clinical development, registration and launch of two major products in Europe, Depocyte ® and Levact ® (Ribomustin ® and Treanda ® ). Dr. Mehrling received his PhD in Pharmacology and MD from the University of Frankfurt, where he previously s
Show less
Read more
Impact Snapshot
Event Time:
ZBH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZBH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZBH alerts
High impacting Zimmer Biomet Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
ZBH
News
- Healthcare Breaches Are More Costly Than Financial Breaches: Here's Why [Forbes]Forbes
- LocatorX Named SupplyTech Breakthroughs' "Asset Tracking Software of the Year" [Yahoo! Finance]Yahoo! Finance
- Blue Mountain and Zifo, Global Leaders in Life Sciences Pharmaceutical Manufacturing, Announce Strategic Partnership to Revolutionize Enterprise Asset Management [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Blue Mountain and Zifo, Global Leaders in Life Sciences Pharmaceutical Manufacturing, Announce Strategic Partnership to Revolutionize Enterprise Asset Management [Yahoo! Finance]Yahoo! Finance
- Unleashing Talent Potential: A Strategic HR Perspective [Yahoo! Finance]Yahoo! Finance
ZBH
Earnings
- 5/2/24 - Beat
ZBH
Sec Filings
- 6/20/24 - Form 3
- 6/20/24 - Form 8-K
- 6/5/24 - Form S-8
- ZBH's page on the SEC website